Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III randomized trial is evaluating Adebrelimab in combination with SHR-8068 and chemoradiotherapy as perioperative therapy for locally advanced recta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Locally Advanced Resectable Rectal Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING